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Abstract. The mAb AA4 binds to novel derivatives of
the ganglioside GD1b on rat basophilic leukemia (RBL-
2H3) cells. Some of the gangliosides are located close
to the high affinity IgE receptor (FCcRI), and binding
of mAb AA4 inhibits FCERI-mediated histamine re-
lease. In the present study, mAb AA4 was found to
bind exclusively to mast cells in all rat tissues exam-
ined. In vitro, within 1 min of mAb AA4 binding, the
cells underwent striking morphologic changes. They
lost their normal spindle shaped appearance, increased
their ruffling, and spread over the surface of the cul-
ture dish. These changes were accompanied by a re-
distribution of the cytoskeletal elements, actin, tubu-
lin, and vimentin, but only the actin was associated
with the membrane ruffles. Binding of mAb AA4 also
induces a rise in intracellular calcium, stimulates
phosphatidyl inositol breakdown, and activates PKC.
M
AST cells and basophils contain a variety of inflam-
matory mediators which are released following
cross-linking of high affinity IgE surface receptors
(FcERI)' . The activation of the receptor results in a com-
plex series of biochemical and morphological events (48) .
Briefly, when FcERI are cross-linked, either by antigen on
IgE-sensitized cells or by antibody directed against the re-
ceptor, there is stimulation of phospholipase C resulting in
hydrolysis ofphosphatidyl inositol with the generation of 1,2
diacylglycerol and inositol 1,3,5 phosphate. Both the 1,2
diacylglycerol and the inositol 1,4,5 phosphate are thought
to act as intracellular signals; the 1,2 diacylglycerol by acti-
vating protein kinase C (PKC), and the inositol 1,4,5 phos-
1. Abbreviations used in this paper: DNP44-HSA, 44 molecules of 2,4-di-
nitrophenyl conjugated to 1 molecule of human serum albumin; EMEM,
Eagle's minimum essential medium with Earl's salts; FcERI, high affinity
IgE receptor on basophils/mast cells; PKC, protein kinase C; NBD,N-[7
Nitrobenz-2-oxa-1,3 diazol-4-yl)] ; RBL-2113, rat basophilic leukemia 2113
cloned cell line.
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However, the extent of these changes was less than
that observed when the cells were stimulated with an-
tigen or antibody directed against the FcERI. None of
these changes associated with mAb AA4 binding were
seen when the cells were exposed to nonspecific IgG,
IgE, or four other anti-cell surface antibodies, nor
were the changes induced by binding mAb AA4 at
4°C or in the absence of extracellular calcium. Al-
though mAb AA4 does not stimulate histamine re-
lease, it enhances the effect of the calcium ionophore
A23187 mediated release. The morphological and bio-
chemical effects produced by mAb AA4 are similar to
those seen following activation of the cell through the
IgE receptor. Therefore, the surface gangliosides which
bind mAb AA4 may function in modulating secretory
events.
phate by mobilizing intracellular calcium pools. Receptor
activation also results in calcium influx, activation of phos-
pholipase A2, the phosphorylation of a number of intracellu-
lar proteins (7), and the rearrangement of the cytoskeleton
before mediator release (35, 37, 48).
The rat basophilic leukemia cell line, RBL-2113, has been
widely used as a model to study FcERI-mediated events (4,
48, 49). A number ofmAbs have been raised against surface
molecules on these cells (3, 5, 29, 50). These mAb were
selected for their ability to either stimulate or inhibit his-
tamine release in the RBL-2113 cells. The majority of the
antibodies were directed against the Fcc-RI; however, two
antibodies, mAb ADl and AA4, bind other cell surface com-
ponents. The mAb ADl binds to a novel 50-60-kD protein
on the surface of the RBL-2113 cells and modulates hista-
mine release (31). The other antibody, mAb AA4, binds
to unique a-galactosyl derivatives of the ganglioside GD,b
(18). These gangliosides are closely related to the FceRl,
both spatially and functionally (5). Binding ofboth the intact
mAb AA4 and its Fab fragments to cells inhibits the binding
635of IgE to its receptor, but bound IgE does not prevent mAb
AA4 from binding. The proximity of the binding site for
mAb AA4 to the FccRI has been further documented by
fluorescence resonance energy transfer experiments (16).
Additionally, binding ofmAb AA4 to the RBL-2H3 cells in-
hibits histamine release in a time- and concentration-
dependent manner. Gangliosides are known to modulate
receptor function in other cell types (19, 25, 54). Therefore,
the present study was undertaken to further characterize the
immediate effects ofthe binding ofmAb AA4 to gangliosides
on the surface of RBL-2H3 cells and to determine if there
were any similarities between the effects produced by bind-
ing of mAb AA4 and activation of the FcER1.
Materials andMethods
Tissue Culture
RBL-2H3 cells were grown in Eagle's minimum essential medium (EMEM)
supplemented with 15 % FCS, penicillin, and streptomycin (4). For light mi-
croscopy, cells were plated at a density of 2 x 104 cells per well in plastic,
8-chamber LabTek Chamber Slides (Nunc Inc., Naperville, IL). For
studies involving the interactive laser cytometer, cells were plated at a den-
sity of 1 x 106 cells in 35-mm culture dishes and for scanning EM, 1 x
104 cells were plated onto 13-mm-round glass coverslips. All cells were
plated 48 h before use.
Antibody Preparation
The isolation and characterization of mAb AA4 has been previously de-
scribed (5). Briefly, spleen cells from mice immunized with intact RBL-
2H3 cells were fused with the X63Ag8-653 myeloma cell line and the
resulting culture supernatants tested for their capacity to inhibit IgE bind-
ing. The immunoglobulins were precipitated from ascites fluid with 40%
saturated ammonium sulfate. For mAb AA4, this step was repeated once
using 50% saturated ammonium sulfate. The immunoglobulins were then
purified by ion exchange chromatography on DE-52 (Whatman, Clifton,
NJ). For some experiments, the mAb AA4 antibodies were further purified
by HPLC using an ion exchange column (Sepherogel TSK DEAE 124; 60-
nun inner diam x 15 cm) followed by a gel filtration column (TSK 3000
SWG; 21.5-mm innerdiam x 60 cm) . Several batches ofascites fluid were
also affinity purified on Gamma-bind G Plus (Genex, Gaithersburg, MD)
as recommended by the manufacturer. Final antibody concentrations were
determinedby the BCA protein assay (Pierce, Rockford, IL). Regardless of
the method of purification, the antibodies appeared as a single band on
Coomassie blue staining following SDS-polyacrylamide gel electrophore-
sis, and had identical effects when tested on RBL-2H3 cells. Fab fragments
of mAb AA4 were prepared by papain digestion of purified antibody. The
fragments were separated by HPLC. The other mAb were purified as de-
scribed previously (5, 50). Antibodies were labeled with 1251 using Io-
dobeads (Pierce, Rockford, IL).
HistamineRelease
Histamine release from RBL-2H3 cells in monolayer cultures was per-
formed as described previously (5). Briefly, cells were plated at 1 x 105
cells per 16-mm-diam well and cultured for 18 h. Themonolayers were then
rinsed twice with EMEM containing 2% BSA and the appropriate secreta-
gogue was added in the same medium. The reagents used and their concen-
trations areas follows: anti-FceRl mAb, mAbBC4, 0.15 mg/ml; mAb AA4,
10 kg/ml; and the calcium ionophore A23187,0.01-0.3 kg/ml (Sigma Chem-
ical Company, St. Louis, MO). For IgE-mediated activation, the cells were
cultured for 2-24 h with 0.3 ug/ml of mAb DNP 48, a monoclonal
anti-dinitrophenol IgE (50). The monolayers were then washed and stimu-
lated with the corresponding antigen, dinitrophenol-human serum albumin
(DNP44-HSA) at 1.0 kg/ml. At varying time intervals, the media were col-
lected and the histamine content determined by the automated fluorometric
technique. In experiments to assess the effects of calcium on histamine re-
lease and on the morphological changes, cells were cultured for 18 h, then
rinsed twice in Hank's Balanced Salt Solution without Ca2+ and Mgt+ and
stimulated in the same medium containing 40 AM EDTA.
The Journal of Cell Biology, Volume 116, 1992
Binding andInternalization ofAntibodies
To determine cell surface binding, 2.2 x 106 cells grown in suspension
culture for 48 h were incubated with 25 kg ofantibody for 90 min at 4°C,
rinsed twice in EMEM, and incubated for an additional 60 min at 4°C
With 5 x 105 CPM of 1251 goat anti-mouse IgG. Aliquots of the cell sus-
pension were counted to determine total activity, and other aliquots were
layered over his (2-ethylhexyl) phtalate: dibutyl phtalate (2:3) (Kodak
Chemicals, Rochester, NY) and centrifuged. The resulting cell pellets were
then counted. Internalization of antibodies was determined by incubating
the cells with 5 kg/ml of "5I-mAb AA4 or 0.5 mg/ml 1151-mAb BC4 for 30
min at 37°C. The cells were rinsed twice in PBS and once in PBS with 1
mM EDTA, and incubated with 0.5 mg/ml proteinase K (Boehringer-
Mannheim Biochemicals, Indianapolis, IN) for 60 min at 4°C. Aliquots of
the cells were then counted directly or centrifuged through his (2-ethyl-
hexyl) phtalate: dibutyl phtalate (2:3).
(3HJMyo-inositol Labeling
[3H]myo-inositol labeling was done as previously described (24, 33). The
cells were plated at 1 x 105 cells per 22-mm well. After 6 h, the medium
was replaced with fresh inositol-free EMEM containing 15 % dialyzed FCS
and 0.4 kCi/ml [3H]myo-inositol . 18 h later, the cells were washed three
times with Pipes ACM (119 mM NaCl, 5 mM KCI, 5.6 mM glucose, 25
mM Pipes, 0.4 mM MgC12, 1 mM CaC12, and 1.0 mg/ml BSA, pH 7.4) and
preincubated for 10 min with Pipes ACM containing 5 mM LiCl. The cells
were then stimulated with 0.1 ug/ml DNP"-HSA, 0.15 kg/ml mAb BC4,
or 10 kg/ml mAb AA4 for 5, 10, 15, 20, 30, or 60 min at 37°C. Lipids were
extracted by adding 3 nil chloroform:methanol (1:2) directly to the medium
in the culture dishes. The liquid was removed, 1 ml chloroform added, and
two phases separated by centrifugation. 1.5 nil of the aqueous phase was
applied to a Dowex-6 column. The column was rinsed three times with 1
nil 5 mM myo-inositol and the inositol phosphates eluted with 1.5 ml 1 M
sodium formate/0.1 M formic acid. Radioactivity ofthe inositol phosphates
was determined try liquid scintillation spectrometry. Data are expressed as
the mean of four experiments t 1 SD. t test was performed to determine
if significant differences exist between experimental groups.
MeasurementofCytosolic Calcium
For [Ca2+]; determinations, cell monolayers were detached from tissue
culture flasks with trypsin-EDTA and placed in suspension culture 2-24 h
before use. Cells were washed twice in EMEM without phenol red contain-
ing 1% BSA and incubated for 45 min at 30°C with Quin 2/AM (15 AM;
Calbiochem, San Diego, CA). They were then washed twice with EMEM
without phenol red containing 0.1% BSA and kept at 30°C. Just before use,
the cells were washed in HBSS without phenol red containing 0.1% BSA,
and 1.5 ml ofcell suspension in this medium was placed in a cuvene and
warmed to 37°C with stirring. Quin 2 fluorescence was measured using an
SLM 8,000 spectrofluorimeter (SLM/Aminco; SLM Instruments, Urbana,
IL) with the slit width adjusted to 4 run and the excitation and emission
wavelengths set at 339 and 495 nm, respectively. The [Ca2+]i was calcu-
lated according to Tsien et al. (52). F,ax was obtained by lysing the cells
with 0.07% Triton X-100, following which Fm; was obtained by stepwise
addition of 10 mM EGTA and 1 M Tris to increase the pH to 8.3. Data are
presented as the mean t 1 SD. t test was performed to determine if
significant differences exist between experimental groups.
InteractiveLaser Cytometry
Monolayer cells in 35-mm culture dishes were rinsed twice in HBSS with-
out phenol red containing 1% BSA. The mAb AA4, BC4, or the antigen
DNP44-HSA was added and the cells were returned to the incubator at
37°C. At varying time intervals (0-60 min), the samples were rinsed twice
in PBS at 37°C andfixed at room temperature for5 min in4% formaldehyde
(Ladd Research Industries, Burlington, VT) in PBS. They were then rinsed
in PBS followed by PBS plus 0.1 M glycine and stained for 1 h in 2 !+M
NBD-dodecanoyl phorbol-13-acetate (Molecular Probes, Inc., Eugene, OR)
(2, 38) . After rinsing with cold PBS, 1 ml of cold PBS containing 0.167 M
sucrose was added to each dish and the plates placed on ice. The staining
of the cells with thefluorescent probe was reduced 60 t 3% when the cells
were stained in the presence of a 10- to 20-fold excess of PMA. The cells
were examined immediately with a Meridian ACAS 470 interactive laser
cytometer (Meridian Instruments, Inc., Okemos, MI). The amount ofdye
bound per cell was determined by measuring the total fluorescence of in-
dividual cells. A minimum of35 cells from four experimentswere examined
636for each treatment and the average of the cells' fluorescence calculated .
Results are expressed as mean ofpercent change in average fluorescence in-
tensity t 1 SD.
Preparation of Cytoskeletal Extracts
Cytoskeletal extracts were prepared according to the method of Pfeiffer et
al . (39) . Following extractions, the samples were runon a 10% SDS-PAGE
and the gels stained with Coomassie blue. The amount ofactin was deter-
mined by scanning the gel with an LKB gel scanner and comparing the area
underthe actin peak in untreated andmAb AA4-treatedcells . To determine
the relative amounts of tubulin and vimentin, the proteins from the
cytoskeletal extracts were separated by SDS-PAGE electrophoresis, trans-
ferred to Immobilon membranes (Millipore, Bedford, MA), and incubated
with antibody to either tubulin or vimentiin (Chemicon, Temecula, CA) .
Antibodies were then detected using biotinylated anti-mouse IgG and strep-
tavidin alkaline phosphatase (Zymed, South San Francisco, CA) .
Light Microscopy
Thedistribution ofmAb AA4 on thesurfaceofRBL-2113 cells was assessed
by adding 200 Al mAb AA4 (1-10 Ag/ml to culture medium at 37°C) per
well of8-well chamber slides and then returning the slides tothe incubator.
At varying time intervals, the cells were rinsed in PBS, fixed for 10 min
in 2 % formaldehyde, rinsed, and stained with goat anti-mouse FITC (Jack-
sonImmunoResearch Laboratories, Inc., West Grove, PA) . In some experi-
ments the cells were fixed before the addition ofmAb AA4 . To stain for
f-actin, cells were rinsed twice in PBS, fixed for 10 min in 2% formalde-
hyde, permeabilized with 0.1% Triton X-100, and stained for 30 min with
FITC-phalloidin (Molecular Probes) . In experiments involving inhibition
with staurosporine (Kyowa Hakko USA, New York, NY), cells were in-
cubated for 30 min inEMEM containing 1% BSA at 37°C in varying con-
centrations of staurosporine, then mAb AA4 was added and the cells in-
cubated for an additional 30 min . For localization of vimentin, cells were
fixed and permeabilized as above, then stained for 1 h at roomtemperature
with a mAb to vimentin (Chemicon), rinsed in PBS and incubated with
FITC-conjugated goat anti-mouse IgG (Jackson ImmunoResearch) . Tubu-
lin was localized by fixing the cells for2 min in 2% formaldehyde, followed
by 5 min in absolute methanol at -20°C . The cells were further permeabi-
lized with 0.1% Triton X-100 for 5 min and stained for 1 h at room tempera-
ture with a polyclonal antibody to tubulin (Polysciences, Inc ., Warrington,
PA) . The cells were rinsed in PBS and incubated for 30 min in FITC-
conjugated goat anti-rabbit IgG (Jackson ImmunoResearch) . Controls con-
sisted of cells incubated without primary antibody or cells incubated with
normal mouse serumor normal mouse IgG instead oftheprimary antibody.
All controls were negative . Changes in cell morphology were quantitated
by scoring a minimum of500 cells from each ofthree experiments . Changes
were assessed on the basis of cell spreading and ruffling . Results are ex-
pressed as percent t SD.
To localizemAb AA4 binding sites in tissue sections, tissues from 250
gm male Sprague-Dawley rats were fixed for 2 h in 4% formaldehyde, de-
hydrated, and embeddedinJB-4 plastic (Polysciences) . 4-Am sections were
mounted on glass slides and the sections treated with xylene for 15 min and
rehydrated to water. The sections were blocked with 1% BSA in PBS and
exposed to mAb AA4 for 2 h at 37°C . After rinsing in PBS, the sections
were treated in AuroProbeLM gold-conjugated goatanti-mouse IgG (Jans-
sen Life Sciences Products, Westbury NY), and the gold silver enhanced
(Intense M ; Janssen) . To identify mast cells, the sections were counter-
stained with toluidineblueor alcian blue . Endocytosis was assessed by rins-
ing the cells twice in EMEM-BSA without phenol red and then adding
EMEM-BSA without phenol red containing 1 mg/ml Lucifer yellow (Mo-
lecular Probes) for 30 min . The cells were rinsed in PBS at 37°C and fixed
for20 min in 2 % formaldehyde at 37°C . All specimens were examined with
a Nikon Microphot-FX microscope .
Scanning Electron Microscopy
Monolayer cells on 13-mm round glass coverslips were rinsed twice in PBS
at 37°C and fixed for 2-4 h at room temperature in 2% glutaraldehyde
(Ladd Research Industries Inc ., Burlington, VT) in PBS, and then rinsed
and stored at 4°C in 0.1 M cacodylate buffer, pH 7.4 . The cells were
postfixed for 2 h in 1% buffered osmium tetroxide, rinsed in distilled water,
and treated for 10 min with 1% aqueous thiocarbohydrizide (EM Sciences,
Fort Washington, PA) . The cells were then treated with osmium again for
30min. The lasttwo steps were repeated once . Following this, the cells were
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dehydrated in ethanol, critically point dried in liquid COZ, and coated with
gold-palladium. Samples were examined in a scanning electron microscope
(35CF ; JEOL USA, Peabody, MA) .
Results
The mAb AA4 binds to novel a-galactosyl derivatives of the
ganglioside GD re (18) which were originally isolated from
RBL-2113 cells, a cell with homology to mucosal mast cells .
The gangliosides were present in the lipid extracts from sev-
eral different rat tissues (18) . Therefore an immunocyto-
chemical survey withmAbAA4 was performed to determine
the distribution of the gangliosides in rat tissues . With the
exception ofbone marrow in all 19 tissues examined, no cells
other than mast cells stained withmAbAA4 (Fig . 1) . Inbone
marrow, a population of large, poorly differentiated cells,
Figure 1 . The mAb AA4 stains only mast cells in tissue sections .
JB-4 plastic sections were treated with 10 pg/ml AA4 followed by
anti-mouse IgG gold . The gold was silver enhanced and the sections
counterstained with toluidine blue . In the liver (A), reaction prod-
uct is localized only in mast cells associated with periportal blood
vessels . No other cells are stained . However, in bone marrow (B)
reaction product is associated with identifiable mast cells as well
as a population ofpoorly differentiated cells. Only cells identifiable
as mast cells by their staining with toluidine blue or alcian blue
were positive with mAbAA4 in all other tissues examined (adrenal
gland, brain, duodenum, epididymis, heart, kidney, lacrimal
gland, lung, parotid gland, pancreas, skeletal muscle, skin, spleen,
sublingual gland, submandibular gland, testis, and thymus) .
637Figure 2 . Scanning electron micrographs ofactivated RBL-2H3 cells. In unstimulated cells (A) the surface is covered with short microvilli .
After 30-min stimulation with antigen (B), anti-receptor antibody, mAb BC4 (C), or mAb AA4 (D), the cells spread and their surface
is ruffled and plicated .
most likely mast cell precursors, stained with mAb AA4 .
The morphology of these cells indicates that they are most
likely immature mast cells. Thus mAb AA4 is mast cell
specific and in tissue sections binds only to cells which can
be identified as mast cells and the gangliosides recognized
by mAb AA4may be considered a marker for rat mast cells .
Initial experiments with RBL-2H3 cells documented the
morphological changes produced by the binding of mAb
AA4 to cell surface gangliosides on RBL-2H3 cells . These
cells are normally spindle shaped, somewhat fibroblastic in
appearance (Fig. 2) with small micro-villi on their surface .
When stimulated to secrete with either antigen or with anti-
FCeRI antibody (mAb BC4), their surface becomes plicated
and the cells flatten and spread . When the RBL-2H3 cells
are exposed to the mAb AA4, 10 jig/ml, the cells undergo
similar morphological changes . The cell surface first be-
comes ruffled and then the cells begin to spread . The mor-
phological changes depend on the concentration of mAb
AA4 added and are less prominent at lower concentrations .
When followed in time lapse video recordings, the effects are
observed immediately upon addition ofmAb AA4, with cell
spreading reaching a maximum by 30 min . The cell shape
slowly returns to normal over the next 1-2 h . These morpho-
logical changes were seen in 97 f 0.01% of the cells exam-
The Joumal of Cell Biology, Volume 116, 1992
ined, while only 4 f 0.9% of untreated cells were morpho-
logically similar to the mAb AA4-treated cells . Unlike the
changes seen with antigen or mAb BC4, the mAb AA4 in-
duced alterations are not accompanied by histamine release
(5) . Although Fab fragments ofmAb AA4 bind to the cells
as seen both in binding studies (5) and by immunofluores-
cence, no morphological changes were observed with Fab
fragments ofmAb AA4 . In addition, four othermAb to non-
receptor proteins on RBL-2H3 cells were also tested . These
mAb all bind approximately the same number of sites as
mAbBC4 (4 x 1(Y) . None of these antibodies had any effect
on the morphology of theRBL-2H3 cells . No morphological
changes were observed when the RBL-2H3 cells were
treated with normal mouse IgG or IgE instead ofmAb AA4,
or when the experiments with mAb AA4 were done at 4°C
or in the absence of calcium . In the present study, the mor-
phological changes could be produced only by binding mAb
AA4 or by activation of the Fcc-RI . Moreover, both mAb
AA4 and Fcc-RI activation produced similar results .
The cross-linking ofthe Fcc-RI proteins with either antigen
or anti-receptor antibodies often results in the clustering of
these receptors and their internalization (27, 34, 35) . It was,
therefore, important to investigate whether the morphologi-
cal changes accompanying mAb AA4 binding affects its dis-
638tribution or results in .its internalization . Following binding,
the mAb AM is uniformly distributed on the cell surface
(Fig . 3) . Even as the cells undergo morphological changes,
mAbAM retains its original distribution . Furthermore, un-
like the results obtained with antigen or mAbBC4, binding
ofmAbAM to the cell surface does not stimulate endocyto-
sis (Fig. 4) and mAbAM remains evenly distributed on the
cell surface with little or no internalization . The apparent
lack of internalization was confirmed using 'III-labeled
mAbAM and mAb BC4 . Following a 30-min incubation of
RBL-2H3 cells with the I'll-labeled antibodies, 95.33 t
0.94% ofthe mAbAM remained on the surface while only
38 f 14.31% of the mAb BC4 was still on the surface . Al-
though FceRI activation normally results in internalization
of the receptor, under certain conditions mast cells will
degranulate without receptor internalization (27, 34) . Pre-
viously, it had been demonstrated that mAb AM binding
to RBL-2H3 cells involves both of its Fab binding regions
(5) . Therefore, the lack of internalization is not because of
the inability of mAb AM to cross-link gangliosides on the
surface (5) .
Figure 3 Surface distribution of mAb AM on RBL-2H3 cells .
Cells which were fixed and then stained with mAb AM followed
by rhodamine-anti-mouse IgG (A) are spindle shaped and themAb
AM is distributed evenly on the cell surface. When the cells were
treated with 10,ug/mlAM for 30 min at 37°C and then fixed and
stained with rhodamine-anti-mouse IgG (B) there is a dramatic
change in cell shape, but the riiAbAM is still evenly distributed
over the cell surface .
Figure 4. mAbAM does not induce endocytosis . To measure endocytosis, cells were exposed to Lucifer yellow for 30 min either in the
presence or absence of antigen or antibody before fixation. There is little uptake of the dye in control (A) or in mAb AM (D) treated
cells when compared to antigen (B), or mAb BC4 (C) stimulated cells .
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639Figure 5 . Changes in F actin staining induced by mAb AA4 . Cells were treated with 10 jg/nd AA4 at 37°C and at varying time intervals
fixed and stained with FITC-Phalloidin . At 0 min (A) actin is localized to aband just under the plasma membrane . A few cells are already
beginning to show some ruffling . By 3 min (B) most of the cells now show some ruffling . Many of the cells are beginning to spread . At
5 min (C) all of the cells show a significant degree of ruffling and are spreading over the surface of the culture dish . By 30 min (D), the
morphological changes are complete, and the cells are spread over the culture dish . Actin is localized in ruffles on the apical surface and
in punctate areas on the basal surface . The response to mAb AA4 is concentration dependent . When the cells are treated with 5 Fcg/nil
mAb AA4 for 30 min (E), the cells are not spread quite as much . At 1 ig/ml (F), the cell morphology is less affected by the antibody,
and many cells are still spindle shaped .
Since mAb AA4 induced such striking morphological
changes in the cell surface, the effects ofmAbAA4 on the
cytoskeleton were examined . Staining the cells forF actin
(Fig . 5) showed that the redistribution of actin began as soon
as the cellswere exposed to the antibody. This redistribution
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continued for 20-30 min, by which time the morphological
changeswere complete with 97.7 f 0.5% ofthe cells exhibit-
ing a redistribution of their actin . The degree of change was
dependent upon the concentration of mAb AA4 (Fig . 5) .
With time, the actin became concentrated in the apical sur-
640Figure6 . The mAbinduces redistribution ofcytoskeletal elements . When untreated cells (A) are stained with FITC-phafoidin, the staining
is primarily associated with the plasma membrane . In cells whichhave been treated with mAb AA4 for30 min (B), the staining for actin
is concentrated in the ruffles at the apical surface and in punctate areas at the basal surface. In untreated cells stained for tubulin (C),
microtubules in the cell body and cytoplasmic processes stain. After exposure to mAbAM for30 min (D), there is adramatic rearrange-
ment of the cytoskeleton and microtubules can be seen radiating from microtubule organizing centers to the cell periphery. In untreated
cells (E), intermediate filaments in the cell body and cytoplasmic process are stained . After 30 minexposure to mAb AM (F), the inter-
mediate filaments are seen in bundles throughout the cells .
face rubies (Fig . 6 b) and in punctate contact points as-
sociated with the basal plasma membrane . When cytoskele-
tal extracts were subjected to SDS-PAGE and Coomassie
blue staining, mAbAM binding resulted in a rapid poly-
merization ofactin which was similar to that seen following
antigen induced secretion (39) . Thetime course ofthe actin
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polymerization paralleled the morphological changes . The
intracellular distribution of two other cytoskeletal compo-
nents, microtubules and intermediate filaments, wasalso ex-
amined (Fig . 6) . ThemAbAM binding resulted in a redis-
tribution ofboth tubulinandvimentin ; howeverunlike actin,
there was no obviousassociation between these cytoskeletal
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Figure 7 . ThemAbAA4 inducedthe hydrolysis ofinositol phospho-
lipids . Following stimulation of RBL-2113 cells with antigen (o) or
anti-receptor antibody mAb BC4 (v), there is an immediate and
sustained release of inositol phosphates into the aqueous phase
as compared to controls (A) . After exposure to mAb AA4 (o)
there is alsoa release of phosphoinositide breakdown products into
the aqueous phase . However, the magnitude is not great as with
activation of the FceRl . Cells were labeled with [ 311]myoinositol
and release of inositol phosphates into the aqueous phase was mea-
sured as outlined in Materials and Methods . Data are expressed as
the mean of four experiments f 1 SD. Antigen induced and mAb
BC4 release of inositol phosphates was significant at p < .001 at
5 min and all later time points when compared to untreated cells
or mAb AA4-treated cells. Release from mAb AA4-treated cells
was also significant at p < .001 .
elements and the surface ruffles . Both the tubulin and vimen-
tin were confined to the cell body. Western blots of the
cytoskeletal extracts revealed no differences in amount of
polymerized tubulin or vimentin between untreated and
mAb AA4-treated cells . This cytoskeletal reorganization in-
duced by binding ofmAb AA4 is similar to that seen when
the FceRI is activated (39) .
These morphological changes induced by binding mAb
AA4 are similar to those produced by activation of the
Fcc-RI . Therefore further experiments investigated whether
similarities existed between the intracellular signals gener-
ated by binding mAb AA4 and those induced following
FceRI activation . When RBL-2113 cells are stimulated with
either antigen or antibody directed against RBL-2113 cells,
there is hydrolysis of the inositol phospholipids (Fig . 7) .
Treatment of the cells with mAb AA4 also resulted in a
significant (p < .01) hydrolysis and release of inositol phos-
phates, although this was considerably less than that seen
with antigen or antibody stimulation (Fig. 7) . These results
suggest that the binding ofmAb AA4 caused the hydrolysis
of inositol phospholipids and the release of inositol phos-
phates probably through the activation of phospholipase C.
Fcc-RI activation with mAb AA4 also results in a rise in
the intracellular calcium levels (Fig. 8) in RBL-2113 cells .
Treatment of the cells with mAb AA4 also resulted in a rise
in intracellular calcium levels (Fig . 8) as measured by Quin-
2 fluorescence . Following the addition of mAb AA4, the
resting [Ca]; levels of 109 f 6.3 nM increased over 3 min
to 149 t 7.5nM (p< .001) . The addition ofthe anti-receptor
mAb BC4 at this. point caused a further rise to 402 t 2.6
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nM . The binding ofmAbAA4 to the RBL-2113 cells hadlit-
tle effect on the cells' capacity to respond to stimulation with
mAb BC4, and the final intracellular calcium level was not
significantly different fromwhenmAbBC4 was used alone.
mAb AD1 (29), which binds to a nonreceptor cell surface
protein was used as a negative control. mAb ADl was unable
to stimulate an increase in intracellular calcium . In the ab-
sence of extracellular calcium in the medium, there was no
measurable increase in intracellular calcium following bind-
ing of mAb AA4 . It is possible that mAb AA4 induces a
slight release of intracellular calcium, but that the release is
not detectable with the present methods. Therefore, mAb
ÁA4 binding results in a moderate, but significant, increase
in the intracellular calcium concentration .
The hydrolysis of phospholipids with the production of di-
acylglycerol mightalso result in the activation ofPKC as well
as producing a rise in intracellular calcium . Phorbol esters,
which stimulate PKC, also produce morphological changes
similar to those seen withmAbAA4 and likemAb AA4, this
stimulation does not result in histamine release . 1-oleoyl-2-
acetylglycerol, a synthetic analogue of diacylglycerol, will
also produce similar morphologic changes in a concentra-
tion dependent manner. Moreover, the mAb AA4 induced
changes can be inhibited by 10- 6 M but not by 10- '° M
staurosporine, an inhibitor of PKC . Evidence for possible
mAbAA4 induced changes inPKC was provided by staining
with NBD-dodecanoyl-phorbol acetate (Fig . 9) . Changes in
fluorescence intensity were observed as early as 5 min in
treated cells and reached a maximum at 30 min . No further
changes were observed after 30-min exposure to antigen or
mAb AA4 . In the nonstimulated RBL-2113 cells (Fig. 9 A),
the PKC staining is concentrated in the cell body with the
highest levels seen in ajuxtanuclear position . By 30 min, in
antigen stimulated cells (Fig . 9 B) or in cells stimulated with
antibody directed against the receptor, there is a 48 f 7 .7
drop in average fluorescence intensity after 30 min of stimu-
lation . In contrast, after exposure to mAb AA4 (Fig . 9 C)
the staining pattern in the cell is similar to that seen in con-
trol cells, but there is a 27 f 2.5% drop in average fluores-
cence intensity. It appears, therefore, that binding of mAb
AA4 did result in significant (p < .001) changes in the stain-
ing pattern, but these changes were attenuated when com-
pared to the signals induced by activation of the FcERI . No
redistribution of the dye was seen . This may be because of
the method used . The dye may not bind to PKC after it is
activated . The residual staining may be a result of binding
of the dye to unactivated PKC or to other cellular compo-
nents .
The direct activation ofPKC in RBL-2113 cells with phor-
bol esters does not result in cell secretion but potentiates the
release induced by calcium ionophores (6, 13) . Because
treatment of RBL-2113 cells with mAb AA4 and phorbol es-
ters results in similar morphological changes, we inves-
tigated the effect ofmAb AA4 binding on calcium ionophore
mediated histamine release. As has been observed previ-
ously, ionophore is an effective stimulus of histamine release
in these cells (45), while the addition ofmAb AA4 to the
cells at concentrations from 1 to 100 pg/ml did not result in
histamine release (5) . However, mAb AA4 acted synergisti-
cally with calcium ionophore to significantly (p< .001) en-
hance histamine release from RBL-2113 cells (Fig . 10) . The
enhancement was dose dependent and was not observed with
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several othermAb that bind to nonreceptor surface proteins
on theRBL-2H3 cells . The effect ofmAb AA4 was immedi-
ate as indicated by the fact that the mAb and the ionophore
could be added together to the cells to produce this effect.
In time course experiments, cells treated with mAb AA4,
washed, and then challenged with calcium ionophore had en-
hanced release for up to 6 h after the addition ofmAb AA4.
Therefore, while mAb AA4 alone does not stimulate hista-
mine release, it can augment the release induced by the cal-
cium ionophore .
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Figure 8. mAb AA4 causes a
rise in [Ca]l . Following stim-
ulation of the RBL-2H3 cells
with anti-receptor antibody
mAb BC4 (A), there was an
immediate sharp rise in the
levels of intracellular calcium
from 109 t 6.3 to 378 t 24
nM (p < .001) . After treat-
ment withmAbAA4 (B) there
was a slow increase in the lev-
els of intracellular calcium to
149 t 7.5 nM (p < .01) . The
mAb AA4 did not interfere
with subsequent stimulation of
the cells with mAb BC4, and
the levels of intracellular cal-
cium rose to those seen with
mAb BC4 alone . Cells were
labeled with Quin-2 and [Ca] ;
determined as detailed in Ma-
terials and Methods . Data are
400
￿
500
￿
expressed as mean of six ex-
periments t 1 SD.
300
The present study has demonstrated that binding of themAb
AA4 to RBL-2H3 cells produces changes similar to those
seen with FCERI activation . Morphological changes include
ruffling of the cell surface and a polymerization and redistri-
bution of cytoskeletal components . Biochemically, binding
ofmAb AA4 produces a slight, but significant, increase in
intracellular calcium, phosphatidyl inositol hydrolysis, and
redistribution of PKC . However, unlike FCERI activation
Figure 9 Redistribution of PKC in RBL-2113 cells . Untreated cells or cells stimulated with antigen or mAb AA4 were stained for PKC
with NBD-dodecanoyl-phorbol acetate . In the untreated cells (A) the highest intensity of staining is in a juxtanuclear position in the cell
body. After FcERI stimulation with DNP44-HSA for 30 min (B), the intensity of staining has dropped dramatically. Following treatment
with mAb AA4 for 30 min (C), the cells show a drop in fluorescence when compared to untreated cells, but the drop is not as great as
that seen in the DNP44-HSA-treated cells .W
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Figure 10. The mAb AA4 enhances the calcium ionophore A23187-
induced histamine release. mAb AA4 and the ionophore were
added simultaneously to the RBL-2113 cells. The effect of mAb
AA4 in potentiating ionophore induced histamine release is depen-
dent upon the concentration of mAb AA4 . Data are expressed as
the mean of replicate samples from two experiments f SD. Hista-
mine release seen with either 1 t4g/ml or 10 r~g/ml was significantly
increased (p < .001) over ionophore alone. (0, no mAb AA4; 9,
1 jcg/ml mAb AA4; o, 10 pg/ml mAb AA4) .
these changes are not accompanied by histamine release, al-
though mAb AA4 does act synergistically with the Cal+
ionophore A23187 to augment histamine release.
The morphological changes in RBL-2113 induced by mAb
AA4 binding are virtually identical to those seen when the
FcERI is activated by antigen or anti-receptor antibodies (39,
45) . With the exception of changes induced by either mAb
AA4 or the phorbol esters, these changes in the RBL-2113
cells are strictly associated with secretion. In a survey of 10
variant lines of RBL-2113 cells, only those cell lines which
released histamine following Fcc-RI stimulation showed any
morphological changes (unpublished observations) . The
changes in the cytoskeleton that accompany cell secretion
are early events and precede actual histamine release (45).
In RBL-2113 cells (44), as well as in other cell types (9, 55),
receptor-mediated cell activation results in the association of
the receptor with cytoskeleton. Studies are now in progress
to determine if binding of mAb AA4 to cells also induces
an association of the FceRI with the cytoskeleton.
The biological importance of gangliosides in cellular
regulation is well recognized (17, 19, 25, 26) . Gangliosides
are known to be receptors for bacterial toxins, function in
cell-cell and cell-substratum interaction as well as acting as
modulators of transmembrane signaling. They can also regu-
late differentiation and serve as differentiation markers in
various cell types. Gangliosides can also modulate receptor
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function (10, 11, 19) . For example, gangliosides inhibit the
tyrosine protein kinase activity of the epidermal growth fac-
tor receptor, the insulin receptor, and the platelet-derived
growth factor receptor. Dimerization or oligomerization of
the epidermal growth factor receptor is considered essential
for tyrosine kinase activation, and GM3 will prevent the di-
merization of the receptor. Recently, using ganglioside
deficient cells, Weis and Davis (54) demonstrated that the au-
tophosphorylation of the receptor is regulated by ganglio-
sides. The ability ofantibodies directed against gangliosides
to produce biological effects is not as well characterized .
Antibodies to gangliosides produce an autoimmune disorder
which closely resembles experimental allergic encephalo-
myelitis (36), inhibit the growth ofBALB/3T3 cells and ham-
ster fibroblasts (31), and enhance the response of T lympho-
cytes to various stimuli (21, 22). Similar to the effects seen
with the RBL-2113 cells, antibodies binding to gangliosides
have been shown to increase cGMP levels, activate PKC (21,
22), stimulate calcium influx (15), and inhibit CAMP produc-
tion (30) in other cell types. However in the case ofthe RBL-
2H3 cells, the cascade of biochemical events induced by
mAb AA4 binding to cell surface gangliosides appears iden-
tical, though attenuated, to that produced with the FceRI
is activated.
In the present study, the binding ofmAb AA4 to RBL-2113
cells had its most pronounced effect on the cytoskeleton. Al-
though little is known about the effect of gangliosides on the
cytoskeleton, the biochemical changes induced by mAb
AA4 binding could all contribute to a rearrangement of the
cytoskeleton. The breakdown of phosphatidyl inositol may
be more important than the increase in intracellular calcium
in producing changes in the cytoskeleton (14, 47) . The prod-
ucts of phosphatidyl inositol hydrolysis can act directly to
exert their effect on the cytoskeleton. In platelets the phos-
phatidylinositol cycle is an important factor in the assembly
ofactin filaments and their association with membranes (12).
Likewise, direct activation ofPKC by phorbol esters is known
to alter cell morphology (8, 20, 28, 40, 43, 46) . PKC phos-
phorylates many intracellular proteins, including a number
of cytoskeeeool components such as myosin light chain (32,
41, 42, 51), microtubule-associated protein-2 (1, 53), and
vimentin (23) . The response of RBL-2113 cells to exposure
to mAb AA4 suggests that the generation of inositol phos-
phates, the increase in intracellular calcium and the extent
of PKC activation are sufficient to affect the cytoskeeeool re-
arrangements which accompany secretion, but are not ade-
quate to simulate exocytosis. Thus mAb AA4 may be useful
in separating the early events of signal transduction from the
later events of exocytosis.
The use of mAbs, such as mAb AA4, could help elucidate
the role of these gangliosides in modulating signal transduc-
tion. Although the exact mechanism by which binding of
mAb AA4 exerts its effects is not known, it is likely that the
gangliosides have a physiological relationship to the FceRI
similar to that seen for the epidermal growth factor receptor
and GM3 (54) . The FcERI receptor and the GM-derived
gangliosides may function by association with common in-
tracellular components. These gangliosides are close to the
FcERI (5, 16) and the intracellular signals induced by mAb
AA4 have similarities to those producedby stimulation of the
Fcc-RI . Preliminary studies in our laboratory have shown that
there are membrane proteins which are different from the
644known FceRI components which are associated with the
GMB-derived gangliosides. These membrane proteins could
be important in transmembrane signaling by mAb AA4 and
perhaps in linking the gangliosides to the FceRI.
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